Analysis of IgG Anti-HEV Antibody Protective Levels During Hepatitis E Virus Reinfection in Experimentally Infected Rhesus Macaques
Supporting Files
-
2 23 2019 ; 2-23-
-
Available in CDC Stacks on 2022-04-11T00:00:00Z
File Language:
English
Details
-
Alternative Title:J Infect Dis
-
Personal Author:
-
Description:Background. ; Secondary spread of hepatitis E virus (HEV) infection occurs often in endemic settings in developing countries. The host immune signatures contributing to protection against subsequent HEV reinfection are unknown. ; Methods. ; Twelve seroconverted rhesus macaques were reinoculated with homologous HEV genotype 1 (gt1, Sar-55) and followed for 115 days. HEV RNA, HEV-specific T-cell responses, IgG anti-HEV antibody, and the IgG anti-HEV avidity index were tested. ; Results. ; Four animals with baseline IgG anti-HEV levels from 1.5 to 13.4 World Health Organization (WHO) U/mL evidenced reinfection as determined by HEV RNA in stool, and increase in IgG anti-HEV levels between 63- and 285-fold (P = .003). Eight animals with baseline IgG anti-HEV levels from 2.8 to 90.7 WHO U/mL did not develop infection or shed virus in feces, and IgG anti-HEV antibody levels were unchanged (P = .017). The 4 reinfected animals showed a lower HEV-IgG avidity index (average 35.5%) than the 8 protected animals (average 62.1%). HEV-specific interferon-gamma–producing T cells were 2-fold higher in reinfected animals (P = .018). ; Conclusions. ; Preexisting antibody and high IgG avidity index (>50%) are important factors for protection against HEV reinfection. HEV-specific T-cell responses were elevated in reinfected animals after subsequent exposure to HEV.
-
Subjects:
-
Keywords:
-
Source:J Infect Dis. 219(6):916-924
-
Pubmed ID:30325442
-
Pubmed Central ID:PMC8996334
-
Document Type:
-
Funding:
-
Volume:219
-
Issue:6
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:e3ac32d92c75ce7e8ba65763d36858583dd6e814a3aff9b3aa09aa655344d9d4
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access